Tag: Samsung Bioepis
“There are inconstancies across biosimilar classes right now”
Thomas Newcomer, VP, Head of US Market Access, Samsung Bioepis shares insightful perspectives on the US and Indian biosimilar markets
BioVoice eMagazine November & December 2023 | Issue 11 | Volume...
The Cover Story profiles India’s 10 Trailblazing MedTech Startups that hold a promising future ahead. Read interviews of Dr Sanjib Banerjee, COO, Veeda Clinical Research and Thomas Newcomer, VP, Samsung Bioepis. Startup Special features BramhAnsh Technologies, Bengaluru. Expert Insights by Raghavan Sampathkumar, ED, FSII and Navjot Singh,ED, Trivitron Healthcare.